Product Information

ADAPALENE-BNZYL PEROX 0.1-2.5% is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3759 per GM under NDC 45802084601. Its NADAC has been published 454 times since Mar 14, 2018.

FDA first approved this application on Jan 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ADAPALENE-BNZYL PEROX 0.1-2.5%

Adapalene and Benzoyl Peroxide
$0.3759per GM

Strength

.1; 2.5 g/100g; g/100g

NDC

45802084601

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

ADAPALENE; BENZOYL PEROXIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205033

FDA Approved

1/23/2018

TE Code

AB

On Market Since

1/24/2018

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for ADAPALENE-BNZYL PEROX 0.1-2.5% has been published 454 times since Mar 14, 2018, and over the history we have for it it has declined 94.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3759 per GM
All-time high$7.0634 (Mar 14, 2018)
All-time low$0.2823 (Jul 22, 2026)
52-week high$0.3873
52-week low$0.2823
Median price$0.7553
Average price$0.9582
Largest weekly change+49.6% (May 17, 2023)
Weeks tracked454
Tracking sinceMar 14, 2018

Price History

1W

-3.0%

1M

+2.1%

3M

+14.3%

6M

+27.4%

1Y

+0.2%

3Y

-36.2%

5Y

-58.0%

All

-94.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Adapalene and Benzoyl Peroxide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ADAPALENE-BNZYL PEROX 0.1-2.5%?

The current National Average Drug Acquisition Cost (NADAC) for ADAPALENE-BNZYL PEROX 0.1-2.5%, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3759 per GM (NDC 45802084601), effective Nov 18, 2026.

How has the price of ADAPALENE-BNZYL PEROX 0.1-2.5% changed over time?

Over the history we have for it, the NADAC for ADAPALENE-BNZYL PEROX 0.1-2.5% has declined 94.7%. It has been tracked across 454 weekly CMS publications since Mar 14, 2018.

What are the highest and lowest recorded NADAC prices for ADAPALENE-BNZYL PEROX 0.1-2.5%?

Since Mar 14, 2018, the NADAC for ADAPALENE-BNZYL PEROX 0.1-2.5% has ranged from a low of $0.2823 (Jul 22, 2026) to a high of $7.0634 (Mar 14, 2018), with a median of $0.7553 per GM.

Are there cheaper alternatives to ADAPALENE-BNZYL PEROX 0.1-2.5%?

No other NADAC-published product currently shares the active ingredient and strength of ADAPALENE-BNZYL PEROX 0.1-2.5% in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ADAPALENE-BNZYL PEROX 0.1-2.5%?

ADAPALENE-BNZYL PEROX 0.1-2.5% (NDC 45802084601) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.